Publications
232
Citations
3,857
Est. group size
~1
Recurring co-author estimate
Active years
22
Publishing since 2005
Brandon M. Triplett's research centers on pediatric blood and marrow transplantation, including haploidentical transplants, CAR T-cell therapies, and management of complications such as graft-versus-host disease and cytokine release syndrome in children with leukemia and other cancers. The work also explores immune recovery after transplant and genetic/immunologic factors affecting relapse risk. Note that a few unrelated publications on quantum dots and perovskite materials appear in this record, likely due to a name-matching mix-up in the underlying data, and should not be attributed to this researcher's actual body of work.
Publication output has fluctuated over the past decade with a general upward trend from 2017 to a peak around 2023, followed by a decline in the most recent years, though this may partly reflect incomplete data for 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Hydrogen-Bonded Organic Framework Enables Phase-Pure Layered Tin Perovskite Nanowires for Room-Temperature Lasing
Journal of the American Chemical Society · 2026
- P-543. Role of respiratory viral infections in Airflow Obstruction after Pediatric Hematopoietic Cell Transplantation
Open Forum Infectious Diseases · 2026
- Quantum dot emission enhancement via coupling with an epsilon-near-zero sublayer
AIP Publishing · 2026
- APQ25-AR-QNAP2025-00170_Supplemental_Online_Material
AIP Publishing · 2026
- Quantum dot emission enhancement via coupling with an epsilon-near-zero sublayer
AIP Publishing · 2026
- APQ25-AR-QNAP2025-00170_Supplemental_Online_Material
AIP Publishing · 2026
- Outcomes of Germline Testing for Children with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation
Blood Advances · 2026
- HLA loss-mediated immune escape of acute leukemias in pediatric patients post haploidentical transplantation
Bone Marrow Transplantation · 2025
- Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patients
Blood Immunology & Cellular Therapy · 2025
- High Grade CRS and/or IEC-HS in Pediatric Patients with Recurrent/Refractory Leukemia Receiving CD123-CAR T Cells Manufactured in the Presence of Dasatinib
Transplantation and Cellular Therapy · 2025
- Immune reconstitution following memory T-cell add back and prophylactic blinatumomab post TCRαβ/CD19-depleted haploidentical transplantation in pediatric patients with high-risk acute leukemia
Blood · 2025
- Relapse of Pediatric Acute Leukemias with Genomic HLA Loss Following Haploidentical Hematopoietic Cell Transplant
Transplantation and Cellular Therapy · 2025
- Memory T-Cell Add Back and Prophylactic blinatumomab Post Tcrαβ Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia
Transplantation and Cellular Therapy · 2025
- Machine Learning Using High-Dimensional Longitudinal Clinical Data Improves the Prediction of Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy · 2025
- AUTOLOGOUS T CELL APHERESIS IS SUCCESSFUL ACROSS PEDIATRIC PATIENT POPULATIONS WITH HEMATOLOGIC MALIGNANCIES, SOLID TUMORS, AND BRAIN TUMORS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
Cytotherapy · 2025
- Blood×27
- Biology of Blood and Marrow Transplantation×21
- Transplantation and Cellular Therapy×19
- Bone Marrow Transplantation×12
- Pediatric Blood & Cancer×9
- Sumithira Vasu
Medicine · The Ohio State University
- Julianna Roddy
Medicine · The Ohio State University
- Hannah Choe
Medicine · The Ohio State University
- Marcos de Lima
Medicine · The Ohio State University
- Ayman Saad
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile